Broadline Capital Founded 2004
Founders Chris Thorne Victor Thorne
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$18M
Portfolio companies 2
Rounds per year 0.12
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.67
Exits -
Key employees -
Stages of investment
Late Stage Venture
Private Equity
Secondary Market
Areas of investment
Asset Management
Incubators
Internet
Medical Device
Wealth Management
Summary

Broadline Capital is the famous VC, which was founded in 2005. The company was established in North America in United States. The main office of represented VC is situated in the New York.

Comparing to the other companies, this Broadline Capital performs on 12 percentage points less the average number of lead investments. The high activity for fund was in 2011. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2017. When the investment is from Broadline Capital the average startup value is 100-500 millions dollars. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies.

The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight EndoSphere Inc., China Rapid Finance, Powermers Inc.. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Medical Device, Life Science.

The current fund was established by Chris Thorne. The overall number of key employees were 6.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Broadline Capital, startups are often financed by Northwater Capital, Rev1 Ventures, Queen City Angels. The meaningful sponsors for the fund in investment in the same round are Rev1 Ventures, Northwater Capital, Queen City Angels. In the next rounds fund is usually obtained by Rev1 Ventures, QED Investors, Ohio Department of Development.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
EndoSphere
Health Care
Life Science
Medical Device
Series A
3M24 Jun 2021 United States, Columbus
EndoSphere
Health Care
Life Science
Medical Device
Series C
3M28 Oct 2016 United States, Columbus
China Rapid Finance
Financial Services
FinTech
Internet
Series B
21M24 Jun 2021 China, Shanghai
China Rapid Finance
Financial Services
FinTech
Internet
Series A
4M30 Sep 2005 China, Shanghai
China Rapid Finance
Financial Services
FinTech
Internet
Series C
75M29 Jul 2015 China, Shanghai
EndoSphere
Health Care
Life Science
Medical Device
Series B
3M26 Apr 2012 United States, Columbus
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Broadline Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: